BioSpace GenePool
   Friday, May 09, 2008 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
TOP SPONSOR

Join more than 8,000 attendees as they share information about the latest innovations in drug development and search for solutions to industry challenges.

Highlights of this year's event:
• Over 360 sessions across 26 content areas
• 40 preconference tutorials
• Over 1000 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
• 500+ exhibiting companies
• Networking Reception at the Boston Museum of Science

Please click here for more information.
Top Stories 
•  Osiris Therapeutics, Inc. (OSIR) and NuVasive, Inc. (NUVA) Enter into Definitive Agreement for Osteocel(R) for Up to $85 Million in Upfront and Milestone Payments More...
•  FDA Delays Decision on Adolor Corporation (ADLR), GlaxoSmithKline (GSK) Bowel Drug More...
•  Enzo Biochem (ENZ) Acquires BIOMOL International, Further Expanding Its Life Sciences Operations More...
•  Spectrum Pharmaceuticals, Inc. (SPPI) Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc. More...
•  Applera Corporation (ABI)s Board of Directors Formally Approves Proposed Separation of Its Celera Business More...
•  Otsuka Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company (BMY) ABILIFY(R) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia More...
•  FDA Grants Priority Review of Talecris Biotherapeutics's Gamunex(R) as a Treatment for Neurological Disorder CIDP More...
•  Bristol-Myers Squibb Company (BMY) CEO Buys 100,000 Shares More...

More Top News
Don't Miss This
INTERNATIONAL MEDICAL DEVICE COMPLIANCE CONGRESS
May 26-27, 2008

www.InternationalDeviceCongress.com
• Sponsored by AdvaMed, Eucomed, ABHI, APPAMED, BVMed, EDMA, MEDEC, MIAA and SNITEM

INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
May 28-29, 2008

www.InternationalPharmaCongress.com
• Sponsored by the Pharmaceutical Compliance Forum at the Paris Marriott Rive Gauche Hotel and Conference Center - Paris, France

Register by April 25, 2008 for early bird discount.

For more information, Email: register@internationalpharmacongress.com or Call: +32-2-467-00-59.
Featured Stories
•  Group Wants FDA To Pull Johnson & Johnson (JNJ) Birth Control Patch Ortho Evra More...
•  University of Oklahoma Researchers Identify New Cancer Gene More...
•  Fetal Gene May Contribute to Diabetes Risk, University of Pennsylvania School of Medicine Study More...
•  Gene Variant Boosts Risk of Severe Diabetic Eye, Kidney Diseases, University of Utah Study More...
•  Immune System Pathway Identified To Fight Allergens, Asthma, University of Pittsburgh School of Medicine Study More...
•  Key Roadblock To Gene Expression Identified: Implications For AIDS, Penn State University and National Institutes of Health (NIH) Study More...
•  How 'Horse Tranquilizer' Stops Depression, University of Manchester Study More...
•  High Fat Diet Linked To Prostate Cancer, M. D. Anderson Cancer Center Study More...

What Are You Worth?
 
More Featured News
Event of the day
13th Annual Pharma & Biotech Licensing Deal Making Summit

May 15-16, 2008
Hyatt Regency New Brunswick
Two Albany Street
New Brunswick, New Jersey 08901

Discover new partners, financing and investment opportunities for growth!

Topics covered include:
• The view from both sides - selection criteria for picking pharmaceutical and biotech partners
• Driving early stage innovation with biotech incubators and corporate venture investments
• Strategies for accessing capital and negotiating the best deal
• New university collaboration models for licensing deals
• Partnership opportunities for antibody, stem cells, and oncology
• Valuing deals and identifying risks of early stage partnering

Event Contact Information:
Phone: 800-599-4950
Email: info@srinstitute.com
Website: http://www.almevents.com/pharmadeals
Latest Market Insight
Drug Approval Trends at the FDA and EMEA

Process improvements, heightened scrutiny and industry response

• Delayed approvals. Regulators are requesting more data to validate or refute conclusions about product risks. This is creating a rise in the size and number of clinical trials as well as overall research budgets.

• Rising R&D costs. Drug developers are continually increasing their R&D expenditures to generate approvable drug applications, despite rising financial pressures in the industry. Emerging technologies such as stem cells, genomics and proteomics are among the most prevalent initiatives being used to identify appropriate drug candidates.

• US generics focus. The FDA is allocating resources to generic drug approvals in an attempt to speed these products to market. However, although Europe has recently developed a clear regulatory path for generic versions of biologicals, this is yet be achieved in the US.

• Regulatory process improvements. Regulators are enhancing their drug review processes with new technologies such as electronic drug applications and technology-based standards for drug review.

Click Here for More Information
Top Jobs
BioTechxus (Fort Worth, Texas) Hot Job of the Day:

Alcon Laboratories
Clinical Pharmacokinetic Team Leader
Work cooperatively with Clinical Pharmacology (CP) personnel, non-departmental Alcon personnel, and outside contractors to achieve Clinical Pharmacology Unit, PKDM department, R and D department, and Alcon goals and objectives.

Pharm Country (Malvern, Pennsylvania) Hot Job of the Day:

Lab Support, A Division Of On Assignment
Technical Project Manager
This position is to be filled by a technical leader with diversified experience in the pharmaceutical industry who will direct process development and process improvement activities in the Drug Product and API Technology departments of WWPD in the QbD framework.

Biotech Bay (San Francisco, California) Hot Job of the Day:

Zoomedia Inc.
Director, Sales
Responsible for achieving and exceeding Zoomedia's Quarterly sales targets. Driver of the sales process from initial contact with prospect to transaction closure. Accountable for projects sold to be on/ or under budget.

Genetown (Rockland, Massachusetts) Hot Job of the Day:

EMD Serono
Manager, POA Meeting Planning
Spearhead the development of POA strategy in conjunction with the Senior Management Steering Committee and communicate same to the content development teams (TA Sales and Marketing/Corporate Communications).

Biotech Beach (San Diego, California) Hot Job of the Day:

Arena Pharmaceuticals, Inc.
Senior Medical Writer
The Senior Medical Writer will be responsible for reviewing and preparing clinical/regulatory documents to support all phases of clinical drug development.

Get Noticed! Add your resume to the BioSpace Career Center!
See more than 5,000 job postings in the BioSpace Career Center!
BioSpace Career Fairs

New BioSpace White Paper!

Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
Read it Now!



We are pleased to present the BioSpace Career Fair in Pharm Country on Thursday, June 5, 2008 at the Hanover Marriott in Whippany, NJ.

BioSpace Career Fairs give job seekers the opportunity to meet face-to-face with the region's elite science industry employers while presenting the opportunity to interview for hundreds of specialized open positions.

CLICK Here to submit your resume for the Pharm Country Career Fair now!

Qualified candidates will receive their invitations and confirmation numbers via email 24 to 48 hours after their resumes have been submitted. Pre-screened and accepted candidates must bring a copy of their invitation with confirmation number to the event.

We look forward to seeing you at the Pharm Country Career Fair!

Pharm Country Career Fair, June 5, 2008
DDT - BioSpace 2008 Career Fair, August 6, 2008
DeviceSpace Career Fair, September 8, 2008
BioCapital Career Fair, September 30, 2008
Biotech Bay Career Fair, October 14, 2008

More information about BioSpace's Career Fairs
Company of the day



Rigel Pharmaceuticals, Inc.
1180 Veterans Boulevard
South San Francisco, California 94080 U.S.A.
Phone: 650-624-1100 Fax: 650-624-1101
View Jobs

Rigel discovers and develops novel, small molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases.
Free Resources
FREE Subscription to BioPharm International.

BioPharm International provides a forum for its readers to exchange practical, hands-on information for developing and manufacturing pharmaceutical products through biotechnology; and serves as a supportive, authoritative voice in the evolving business, regulatory, scientific, and technical areas of the biopharmaceutical industry.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the BioSpace GenePool here.

Safely unsubscribe from Biospace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.
Contact Us
Send questions and comments to the BioSpace NewsBeat Team East Coast Office:
    BioSpace, Inc.
    Ramshorn Executive Centre
    2399 Highway 34, Building A-5
    Manasquan, New Jersey 08736-1528 U.S.A.
    Phone: 732-528-3688
    Fax: 732-528-3668
West Coast Office:
    BioSpace, Inc.
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    Annalyn Aquino
    Suvarna Bhatt
    Lana Ho
BioSpace.com - Where Life Sciences Thrive.
Legal Notice
• BioSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2008 BioSpace http://www.biospace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.